Merck & Co. Stock News

With many of the Magnificent 7 stocks reporting earnings the week of October 28, investors' attention was on technology stocks. But that means you may have overlooked two biopharmaceutical companies that delivered solid earnings reports.

Recent data cited by Bloomberg reveals that deadly fungi, including Candida auris, have been spreading globally since the COVID-19 pandemic. Climate change has enabled many of these illness-causing agents to adapt to higher temperatures, making them even more potent challengers to the body's natural defenses, which operate at around 37ºC.

Seeking Alpha's Investing Group leaders presented their earnings assessments from Mag 7 tech giants. Are investors missing hidden opportunities with BDCs, CEFs, mREITs, and preferreds? The case is made for breaking up Realty Income.

The Dow finished October down slightly. Should you buy any of these blue chips?

These are the kinds of stocks that can allow investors to sleep easy at night.

"The Dow® [adds a stock] if the company has an excellent reputation,

The next few years might get bumpy for the pharmaceutical giant, but the longer term looks better.

Start Time: 09:00 January 1, 0000 10:00 AM ET Merck & Co., Inc. (NYSE:MRK ) Q3 2024 Earnings Call October 31, 2024, 09:00 AM ET Company Participants Peter Dannenbaum - SVP, IR Rob Davis - Chairman and CEO Caroline Litchfield - CFO Dean Li - President of Merck Research Labs Conference Call Participants Chris Shibutani - Goldman Sachs Daina Graybosch - Leerink Partners Chris Schott - JPMorgan Ter...